IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice
Molecular Neurobiology · 2024
DOI: 10.1007/s12035-024-04203-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2024. Verfasst von Jing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Interleukin-17, src-Family Kinases, Signal Transduction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Inflammation is an important pathogenic driving force in the genesis and development of epilepsy. The latest researches demonstrated that IL-17A mediated blood-brain barrier (BBB) dysfunction through disruption of tight junction protein expression. To investigate whether IL-17A is involved in BBB disruption after acute seizure attack, the pilocarpine model was established with C57BL/6 J (wild type, WT) and IL-17R-deficient mice in vivo and with primary cultured rat brain microvascular endothelial cells in vitro. The mortality rate and brain water content were evaluated at 24 h after status epilepticus, and IL-17A concentration, endothelial tight junction, adherens junction proteins, and albumin leakage were assessed at 0 h, 4 h, 12 h, and 24 h after status epilepticus (SE). IL-17R-deficient mice showed lessen severity of epilepsy than WT mice, accompanied by less albumin leakage, reduced brain water content, decreased IL-17A, and upregulated expression of target proteins (ZO-1, Occludin and VE-cadherin). IL-17R knockout abrogated abnormal upregulation of Src kinase and phosphorylated Src kinase in the setting of SE, and Src kinase inhibitor PP1 abrogated IL-17A-induced SE related endothelial injury in vitro. In conclusion, IL-17A inhibition might be a promising therapeutic option to attenuate endothelial cell injury and further BBB disruption by reducing Src kinase activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
- Department of Neurology, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Neurology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. ding.jing@zs-hospital.sh.cn.
- CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai, China. ding.jing@zs-hospital.sh.cn.
- CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai, China.
Zitieren
APA
Wang, J., Wu, T., Zhao, Y., Mao, L., Ding, J., & Wang, X. (2024). IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04203-7
Vancouver
Wang J, Wu T, Zhao Y, Mao L, Ding J, Wang X. IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice. Molecular Neurobiology. 2024. doi:10.1007/s12035-024-04203-7
BibTeX
@article{Wang2024,
author = {Wang, Jing and Wu, Tingting and Zhao, Yanan and Mao, Lingyan and Ding, Jing and Wang, Xin},
title = {IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice},
journal = {Molecular Neurobiology},
year = {2024},
doi = {10.1007/s12035-024-04203-7}
}
EUVIMED